跳至主要内容
临床试验/NCT06526481
NCT06526481已完成不适用

Nasoseptal Double Flap Versus Rescue Flap in Endoscopic Transsphenoidal Pituitary Surgery

Mansoura University2 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2022年12月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
56
试验地点
2
主要终点
Nasal morbidity

研究概览

简要总结

This paper investigates the outcomes of two surgical techniques-nasoseptal double flap and nasoseptal rescue flap-used in endoscopic transsphenoidal surgery for pituitary tumors. The nasoseptal flap technique has significantly reduced the incidence of postoperative Cerebrospinal Fluid (CSF) leaks but can cause nasal morbidity.

详细描述

The study aims to compare nasal morbidity and function between the two techniques in patients undergoing this type of surgery. Each patient's nasal morbidity, olfaction, and postoperative complications will be assessed using various tools.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Single blinded study, only the participant is blinded to the group he is going to be in.

入排标准

性别
All
接受健康志愿者

入选标准

  • All consecutive patients with symptomatic pituitary macroadenoma
  • Tumor size ≥ 2 cm

排除标准

  • -Absent sphenoid pneumatization.
  • Temporal or frontal extension.
  • Recurrent pituitary tumor after previous surgery.
  • Previous nasal surgery.
  • Associated nasal disease e.g. rhinosinusitis.
  • Unfit for general anesthesia.
  • Refusal of surgical intervention or signing consent.

结局指标

主要结局

Nasal morbidity

时间窗: at baseline preoperative and 1 month and 3 months postoperative.

Sinonasal Outcome Test 22 (SNOT-22) arabic translation questionnaire for nasal morbidity SinoNasal Outcome Test - 22 abbreviated (SNOT-22) includes 22 items for assessment by the patient. Each item is graded from 0 to 5. The minimum score is 0. The maximum score is 110. High score means higher nasal morbidity. Low scores mean better nasal morbidity.

次要结局

  • Operative data(at time of surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验